A client is scheduled for a transvaginal ultrasound in two weeks.

The client asks the nurse what they should do to prepare for the test.

What is the best response by the nurse?

The correct answer is choice D. The client has a history of placenta previa.

Placenta previa is a condition where the placenta covers all or part of the cervix, blocking the baby’s exit from the uterus.

This can cause severe bleeding during pregnancy and delivery and increase the risk of complications for both the mother and the baby.

Therefore, the nurse should report this condition to the provider before performing an amniocentesis.

Choice A is wrong because having Rh-negative blood type is not a contraindication for amniocentesis.

However, the client may need an injection of Rh immunoglobulin after the procedure to prevent Rh sensitization.

Choice B is wrong because having a history of preterm labor is not a contraindication for amniocentesis.

However, the client may need to be monitored closely for signs of preterm labor after the procedure.

Choice C is wrong because having a history of gestational diabetes is not a contraindication for amniocentesis.

However, the client may need to have their blood glucose levels checked before and after the procedure.

Amniocentesis is a diagnostic procedure that involves removing and testing a small sample of amniotic fluid from the uterus for genetic or chromosomal conditions, such as Down syndrome, Edwards syndrome or Patau syndrome.

It can also be used to diagnose fetal infections, treat excess amniotic fluid, or test fetal lung maturity

"It is a screening test for spinal defects in the fetus."

The MSAFP test is a blood test that measures the amount of alpha-fetoprotein (AFP) in the mother’s blood.

AFP is a protein produced by the baby during pregnancy.The test helps to assess the baby’s risk of certain birth defects, such as neural tube defects, which are abnormalities in the development of the brain and spine.

A. “It is a diagnostic test for spinal defects in the fetus.” This statement is wrong because the MSAFP test is not a diagnostic test.

It only indicates the probability of having a spinal defect, but it does not confirm or rule out the condition.A diagnostic test, such as an ultrasound or amniocentesis, is needed to make a definitive diagnosis.

C. “It is a diagnostic test for chromosomal abnormalities in the fetus.” This statement is wrong because the MSAFP test is not a diagnostic test for chromosomal abnormalities either.

It only indicates the probability of having a chromosomal abnormality, such as Down syndrome, but it does not confirm or rule out the condition.A diagnostic test, such as a chorionic villus sampling (CVS) or amniocentesis, is needed to make a definitive diagnosis.

D. “It is a screening test for chromosomal abnormalities in the fetus.” This statement is partially correct, but not the best answer.

The MSAFP test alone is not very accurate for screening chromosomal abnormalities.It is usually combined with other blood tests and an ultrasound to form a more reliable screening test called a quad screen or an integrated screen.

The normal range of MSAFP levels varies depending on the gestational age of the baby and the laboratory methods used.Generally, the MSAFP levels increase until about 15 weeks of pregnancy and then decrease until delivery.The average MSAFP level at 15 weeks of pregnancy is about 38 ng/mL.However, different laboratories may have different reference ranges, so it is important to consult your healthcare provider for your specific results and interpretation.